[저자] John S. Kim, Yifei Sun, Pallavi Balte, Mary Cushman, Rebekah Boyle, Russell P. Tracy, Linda M. Styer, Taison D. Bell, Michaela R. Anderson, Norrina B. Allen, Pamela J. Schreiner, Russell P. Bowler, David A. Schwartz, Joyce S. Lee, Vanessa Xanthakis, Margaret F. Doyle, Elizabeth A. Regan, Barry J. Make, Alka M. Kanaya, Sally E. Wenzel, Josef Coresh, Carmen R. Isasi, Laura M. Raffield, Mitchell S. V. Elkind, Virginia J. Howard, Victor E. Ortega, Prescott Woodruff, Shelley A. Cole, Joel M. Henderson, Nicholas J. Mantis, Monica M. Parker, Ryan T. Demmer, Elizabeth C. Oelsner
[Category] update2024,
[Article Type] Article
[Source] PMC
The antibody response to COVID-19 vaccines varies among individuals. Here the authors find that older age, male sex, smoking, higher BMI, vaccine type, and certain comorbidities are associated with lower anti-S1 antibody levels after COVID-19 vaccinations, indicating that certain groups might benefit from higher frequency or doses of vaccination.
All Keywords
【저자키워드】 antibodies, SARS-CoV-2, Risk factors, Epidemiology,